Literature DB >> 10753184

XPD polymorphisms: effects on DNA repair proficiency.

R M Lunn1, K J Helzlsouer, R Parshad, D M Umbach, E L Harris, K K Sanford, D A Bell.   

Abstract

XPD codes for a DNA helicase involved in transcription and nucleotide excision repair. Rare XPD mutations diminish nucleotide excision repair resulting in hypersensitivity to UV light and increased risk of skin cancer. Several polymorphisms in this gene have been identified but their impact on DNA repair is not known. We compared XPD genotypes at codons 312 and 751 with DNA repair proficiency in 31 women. XPD genotypes were measured by PCR-RFLP. DNA repair proficiency was assessed using a cytogenetic assay that detects X-ray induced chromatid aberrations (breaks and gaps). Chromatid aberrations were scored per 100 metaphase cells following incubation at 37 degrees C (1.5 h after irradiation) to allow for repair of DNA damage. Individuals with the Lys/Lys codon 751 XPD genotype had a higher number of chromatid aberrations (132/100 metaphase cells) than those having a 751Gln allele (34/100 metaphase cells). Individuals having greater than 60 chromatid breaks plus gaps were categorized as having sub-optimal repair. Possessing a Lys/Lys751 genotype increased the risk of sub-optimal DNA repair (odds ratio = 7.2, 95% confidence interval = 1.01-87.7). The Asp312Asn XPD polymorphism did not appear to affect DNA repair proficiency. These results suggest that the Lys751 (common) allele may alter the XPD protein product resulting in sub-optimal repair of X-ray-induced DNA damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753184     DOI: 10.1093/carcin/21.4.551

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  118 in total

1.  Functional characterization of Ape1 variants identified in the human population.

Authors:  M Z Hadi; M A Coleman; K Fidelis; H W Mohrenweiser; D M Wilson
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.

Authors:  Ling Yuan; Dan Cui; Er-Jiang Zhao; Chen-Zhi Jia; Li-Dong Wang; Wei-Quan Lu
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

3.  No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis.

Authors:  Ming Yin; Jingrong Yan; Alexandra Voutsina; Carmelo Tibaldi; David C Christiani; Rebecca S Heist; Rafael Rosell; Richard Booton; Qingyi Wei
Journal:  Lung Cancer       Date:  2010-11-13       Impact factor: 5.705

4.  Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?

Authors:  Arantza Fariña Sarasqueta; Gesina van Lijnschoten; Valery E P P Lemmens; Harm J T Rutten; Adriaan J C van den Brule
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

5.  Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer.

Authors:  Mary A Bewick; Robert M Lafrenie; Michael S C Conlon
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

6.  Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population.

Authors:  Mehmet Burak Aktuglu; Mesut Ayer; Elif S Bireller; Cagla Rencuzogullari; Hasan Acik; Zeynep Karaali; Taner Alioglu; Namik Yigit; Mustafa Velet; Eray Atalay; Oznur Sari Ure; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2014-08-26       Impact factor: 3.064

7.  Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.

Authors:  Rujiao Liu; Xiaoying Zhao; Xin Liu; Zhiyu Chen; Lixin Qiu; Ruixuan Geng; Weijian Guo; Guang He; Jiliang Yin; Jin Li; Xiaodong Zhu
Journal:  Tumour Biol       Date:  2015-08-28

8.  Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Authors:  Christopher E Aston; David A Ralph; Dominique P Lalo; Sharmila Manjeshwar; Bobby A Gramling; Daniele C DeFreese; Amy D West; Dannielle E Branam; Linda F Thompson; Melissa A Craft; Debra S Mitchell; Craig D Shimasaki; John J Mulvihill; Eldon R Jupe
Journal:  Hum Genet       Date:  2004-12-21       Impact factor: 4.132

9.  Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer.

Authors:  Marjun P Duldulao; Wendy Lee; Rebecca A Nelson; Joyce Ho; Maithao Le; Zhenbin Chen; Wenyan Li; Joseph Kim; Julio Garcia-Aguilar
Journal:  Cancer       Date:  2012-10-23       Impact factor: 6.860

10.  Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.

Authors:  Kathleen M McCarty; Thomas J Smith; Wei Zhou; Ernesto Gonzalez; Quazzi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Louise Ryan; Li Su; David C Christiani
Journal:  Carcinogenesis       Date:  2007-04-29       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.